2023 Microbiome Market Trends Report 2023: Market is Successfully Commercializing Seres Therapeutics' SER-109 and Rebiotix's RBX-2660 for Recurrent Clostridium Difficile Infection
/PRNewswire/ -- The "2023 Microbiome Market Trend" report has been added to ResearchAndMarkets.com's offering. The microbiome therapeutics market is...
Source: prnewswire.com